Brief: Diamyd Medical Contracts Global CRO For Phase III Trial With Diabetes Vaccine Diamyd

Diamyd Medical AB

15/04/2021 11:16

April 15 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL CONTRACTS GLOBAL CRO FOR PHASE III TRIAL
WITH THE
DIABETES VACCINE DIAMYD®
    * TRIAL IS EXPECTED TO BEGIN RECRUITING PATIENTS LATER THIS
YEAR
    * TRIAL TO CONFIRM EFFICACY AND SAFETY OF DIAMYD IN
INDIVIDUALS
DIAGNOSED WITH TYPE 1 DIABETES WHO CARRY HAPLOTYPE HLA DR3-DQ

Source text for Eikon:  ID:nWkr6HXjMt 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))